fbpx

Stem cell treatment failed to reduce inflammation in MS

Stem cell treatment failed to reduce inflammation in MS Published: 28 October 2021 Treatment with mesenchymal stem cells (MSCs) has failed to significantly reduce inflammation in the brain of adults with multiple sclerosis (MS) in a phase 2 clinical trial. The into-the-vein treatment also failed to improve other clinical aspects
Read More

Beetroot molecule may hold hope for MS treatment

Beetroot molecule may hold hope for MS treatment Published: 05 November 2020 Researchers have discovered that a small protein found in beetroot can block the activity of prolyl oligopeptidase (POP), an enzyme that breaks down certain hormones and signalling molecules and which controls inflammation in the body.    The study, published
Read More

Intranasal drug slows MS progression in mice study

Intranasal drug slows MS progression in mice studyPublished: 22 October 2020 A new study has found that an anti-inflammatory drug administered nasally may reduce the progression of multiple sclerosis (MS) in mice.  Researchers focused on molecules called inflammasomes which are responsible for the activation of the inflammatory response in the
Read More